FDA Adverse Event Malfunction Summary report: N

FINELINE II

MDR report key: 2057573 · Received April 14, 2011

Report

Report Number
2124215-2011-05622
Event Type
Malfunction
Date Received
April 14, 2011
Date of Event
March 21, 2011
Report Date
May 19, 2011
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

THE LEAD HAS BEEN EXPLANTED AND WILL BE RETURNED. NO FURTHER INFORMATION IS AVAILABLE. THIS REPORT WILL BE UPDATED IF MORE INFORMATION BECOMES AVAILABLE.

Additional Manufacturer Narrative · 1

THE LEAD REMAINS IN SERVICE. NO FURTHER INFORMATION IS AVAILABLE. THIS REPORT WILL BE UPDATED IF MORE INFORMATION BECOMES AVAILABLE.

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A THOROUGH EVALUATION OF THE LEAD WAS PERFORMED. ONLY A PROXIMAL SEGMENT OF THE LEAD WAS RETURNED WITH A TOTAL LENGTH OF 402 MILLIMETERS. VISUAL ANALYSIS CONFIRMED DISCONTINUOUS FILARS 225 MILLIMETERS FROM THE TERMINAL PIN. THE COIL WIRES WERE FRACTURED AT THE DISTAL END OF THE RETURNED PORTION. EVIDENCE INDICATES THAT A SUTURE SLEEVE WAS LIKELY POSITIONED FROM 231-255 MILLIMETERS WHILE THE LEAD WAS IMPLANTED. IN CONCLUSION, LABORATORY ANALYSIS CONFIRMED THE FIELD ALLEGATION OF LEAD FRACTURE.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE LEAD SAFETY SWITCH FOR THIS RIGHT ATRIAL (RA) LEAD WAS ACTIVATED DUE TO HIGH IMPEDANCE MEASUREMENTS GREATER THAN 2500 OHMS. ADDITIONALLY, NOISE WAS NOTED ALONG WITH OVERSENSING IN BOTH UNIPOLAR AND BIPOLAR CONFIGURATIONS. THE LEAD WAS NOT ABLE TO CAPTURE IN THE ATRIUM. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED ADDITIONAL INFORMATION THAT THIS RIGHT ATRIAL (RA) LEAD WAS FOUND TO BE FRACTURED APPROXIMATELY 3 INCHES FROM THE TERMINAL PIN. THE LEAD WAS EXPLANTED DURING A DEVICE CHANGE OUT PROCEDURE FOR NORMAL BATTERY DEPLETION. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FINELINE II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4472

Patients

Seq Age Sex Outcome Treatment
1 54 YR 4034| 4472| 1298